Monday, October 26, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 5, 2026

Overseas Layout of Chinese Passenger Car OEMs and Supply Chain Company Research Report 2026: Accelerated Release of OEM Overseas Production Capacity, Chinese Intelligent Supply Chain Goes Global

View original at globenewswire.com
Overseas Layout of Chinese Passenger Car OEMs and Supply Chain Company Research Report 2026: Accelerated Release of OEM Overseas Production Capacity, Chinese Intelligent Supply Chain Goes Global Dublin, March 05, 2026 (GLOBE NEWSWIRE) -- The "Research Report on Overseas Layout of Chinese Passenger Car OEMs and Supply C…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Starting from 2025, the release of overseas production capacity by Chinese OEMs will accelerate

    80% confidence

  • Establishing overseas factories by OEMs can not only cope with trade protectionism such as tariffs but also get closer to local markets to boost sales

    80% confidence

  • As long as there are no major changes in the international market environment, China's automotive export potential remains enormous

    80% confidence

  • It is expected that the overseas sales of Chinese automotive brands will exceed 10 million units by 2030

    80% confidence

  • New energy automotive supply chain enterprises and automotive intelligent supply chain enterprises have achieved greater overseas revenue growth, more production base plans, and faster implementation compared with traditional auto parts enterprises

    80% confidence

  • From January to November 2025, China exported 7.33 million vehicles, a year-on-year increase of 25%

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com
Overseas Layout of Chinese Passenger Car OEMs and Supply Chain Company Research Report 2026: Accelerated Release of OEM Overseas Production Capacity, Chinese Intelligent Supply Chain Goes Global — Source | Via News | ViaNews Market